Sage Therapeutics, Inc. (SAGE) Ownership

$6.22

north_east
$0.08 (1.3%)
Day's range
$6.08
Day's range
$6.53

Sage Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 4.85 M $26.34 M   -10.02% 7.94%
VANGUARD GROUP INC 02/11/2025 4.84 M $26.27 M   -16.01% 7.92%
BELLEVUE GROUP AG 02/14/2025 4.46 M $24.22 M   0.00% 7.30%
FMR LLC 02/13/2025 4.12 M $22.36 M   -21.89% 6.74%
CALIGAN PARTNERS LP 02/14/2025 3.05 M $16.58 M   100.00% 4.99%
RTW INVESTMENTS, LP 02/14/2025 3.00 M $16.30 M   -46.31% 4.91%
MILLENNIUM MANAGEMENT LLC 02/14/2025 1.62 M $8.82 M   8.32% 2.66%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 1.59 M $8.60 M   67.44% 2.59%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 1.39 M $7.54 M   100.00% 2.27%
STATE STREET CORP 02/14/2025 1.27 M $6.91 M   -56.51% 2.08%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.26 M $6.83 M   1.13% 2.06%
FEDERATED HERMES, INC. 02/13/2025 1.11 M $6.00 M   63.73% 1.81%
D. E. SHAW & CO., INC. 02/14/2025 720,105 $3.91 M   11.29% 1.18%
683 CAPITAL MANAGEMENT, LLC 02/14/2025 630,000 $3.42 M   5.00% 1.03%
JEFFERIES FINANCIAL GROUP INC. 02/27/2025 599,042 $3.25 M   -3.76% 0.98%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 560,429 $3.04 M   38.80% 0.92%
GOLDMAN SACHS GROUP INC 02/11/2025 542,247 $2.94 M   -29.61% 0.89%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 485,355 $2.64 M   -0.81% 0.79%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 462,309 $2.51 M   2.24% 0.76%
JANE STREET GROUP, LLC 02/14/2025 462,004 $2.51 M   103.10% 0.76%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 450,795 $2.45 M   -12.18% 0.74%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 414,221 $2.25 M   -8.08% 0.68%
HUDSON BAY CAPITAL MANAGEMENT LP 02/14/2025 247,000 $1.34 M   -28.41% 0.40%
PDT PARTNERS, LLC 02/14/2025 235,097 $1.28 M   37.25% 0.38%
LAZARD ASSET MANAGEMENT LLC 02/14/2025 222,726 $1.21 M   100.00% 0.36%
PINNACLE ASSOCIATES LTD 02/14/2025 220,198 $1.20 M   30.62% 0.36%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 02/14/2025 215,871 $1.17 M   100.00% 0.35%
JPMORGAN CHASE & CO 02/12/2025 181,354 $984,752   20.24% 0.30%
BANK OF NEW YORK MELLON CORP 02/04/2025 171,444 $930,941   -5.33% 0.28%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2025 169,057 $917,980   157.86% 0.28%
VERITION FUND MANAGEMENT LLC 02/14/2025 169,015 $917,751   23.89% 0.28%
UBS GROUP AG 02/14/2025 162,890 $884,493   -2.72% 0.27%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 152,726 $829,303   100.00% 0.25%
HRT FINANCIAL LP 02/14/2025 150,827 $818,000   -12.34% 0.25%
TREXQUANT INVESTMENT LP 02/12/2025 144,662 $785,515   -17.65% 0.24%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 142,694 $774,829   0.00% 0.23%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/12/2025 139,748 $759,000   100.00% 0.23%
TORONTO DOMINION BANK 02/19/2025 136,723 $742,406   100.00% 0.22%
TWO SIGMA INVESTMENTS, LP 02/14/2025 129,750 $704,542   -19.81% 0.21%
AMERIPRISE FINANCIAL INC 02/14/2025 125,630 $682,171   -41.29% 0.21%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 120,723 $655,526   -35.11% 0.20%
TWO SIGMA ADVISERS, LP 02/14/2025 117,799 $639,649   -2.16% 0.19%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 108,200 $587,526   0.00% 0.18%
AMERICAN CENTURY COMPANIES INC 02/11/2025 106,792 $579,881   -67.89% 0.17%
BARCLAYS PLC 02/13/2025 95,448 $518,000   -25.31% 0.16%
INVESCO LTD. 02/13/2025 92,528 $502,427   5.27% 0.15%
SWISS NATIONAL BANK 02/10/2025 88,600 $481,098   0.00% 0.15%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/14/2025 87,981 $477,737   -72.76% 0.14%
RHUMBLINE ADVISERS 01/30/2025 87,323 $474,151   1.44% 0.14%
CITIGROUP INC 02/12/2025 85,793 $465,856   24.15% 0.14%

Sage Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 276 institutional investors and hedge funds held shares of Sage Therapeutics, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 4.85 M

VANGUARD GROUP INC: 4.84 M

Bellevue Group AG: 4.46 M

FMR LLC: 4.12 M

Caligan Partners LP: 3.05 M

RTW INVESTMENTS, LP: 3 M

83.81% of Sage Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 69.25 M shares in the last 24 months. This purchase volume represents approximately $430.71 M in transactions.